Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.

Tweed CD, Crook AM, Dawson R, Diacon AH, McHugh TD, Mendel CM, Meredith SK, Mohapi L, Murphy ME, Nunn AJ, Phillips PPJ, Singh KP, Spigelman M, Gillespie SH.

BMC Pulm Med. 2019 Aug 14;19(1):152. doi: 10.1186/s12890-019-0907-6.

2.

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.

Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, Conradie F, Dalai D, van Deun A, Dat PT, Lan N, Master I, Mebrahtu T, Meressa D, Moodliar R, Ngubane N, Sanders K, Squire SB, Torrea G, Tsogt B, Rusen ID; STREAM Study Collaborators.

N Engl J Med. 2019 Mar 28;380(13):1201-1213. doi: 10.1056/NEJMoa1811867. Epub 2019 Mar 13.

3.

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study.

Murphy ME, Wills GH, Murthy S, Louw C, Bateson ALC, Hunt RD, McHugh TD, Nunn AJ, Meredith SK, Mendel CM, Spigelman M, Crook AM, Gillespie SH; REMoxTB consortium.

BMC Med. 2018 Oct 17;16(1):189. doi: 10.1186/s12916-018-1169-5.

4.

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.

Tweed CD, Crook AM, Amukoye EI, Dawson R, Diacon AH, Hanekom M, McHugh TD, Mendel CM, Meredith SK, Murphy ME, Murthy SE, Nunn AJ, Phillips PPJ, Singh KP, Spigelman M, Wills GH, Gillespie SH.

BMC Infect Dis. 2018 Jul 11;18(1):317. doi: 10.1186/s12879-018-3230-6.

5.

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.

Murphy ME, Phillips PPJ, Mendel CM, Bongard E, Bateson ALC, Hunt R, Murthy S, Singh KP, Brown M, Crook AM, Nunn AJ, Meredith SK, Lipman M, McHugh TD, Gillespie SH; REMoxTB Consortium.

BMC Med. 2017 Oct 27;15(1):192. doi: 10.1186/s12916-017-0947-9.

6.

Sharing data from clinical trials: the rationale for a controlled access approach.

Sydes MR, Johnson AL, Meredith SK, Rauchenberger M, South A, Parmar MK.

Trials. 2015 Mar 23;16:104. doi: 10.1186/s13063-015-0604-6.

7.

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.

Nunn AJ, Rusen ID, Van Deun A, Torrea G, Phillips PP, Chiang CY, Squire SB, Madan J, Meredith SK.

Trials. 2014 Sep 9;15:353. doi: 10.1186/1745-6215-15-353.

8.

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.

Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, Pappas F, Phillips PP, Nunn AJ; REMoxTB Consortium.

N Engl J Med. 2014 Oct 23;371(17):1577-87. doi: 10.1056/NEJMoa1407426. Epub 2014 Sep 7.

9.

Penicillin to prevent recurrent leg cellulitis.

Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, Nasr IS, Brindle RJ, English J, Meredith SK, Reynolds NJ, de Berker D, Mortimer PS, Williams HC; U.K. Dermatology Clinical Trials Network's PATCH I Trial Team.

N Engl J Med. 2013 May 2;368(18):1695-703. doi: 10.1056/NEJMoa1206300.

10.

Health related quality of life after combined hormone replacement therapy: randomised controlled trial.

Welton AJ, Vickers MR, Kim J, Ford D, Lawton BA, MacLennan AH, Meredith SK, Martin J, Meade TW; WISDOM team.

BMJ. 2008 Aug 21;337:a1190. doi: 10.1136/bmj.a1190.

11.

The ethics of non-inferiority trials.

Nunn AJ, Meredith SK, Spigelman MK, Ginsberg AM, Gillespie SH.

Lancet. 2008 Mar 15;371(9616):895; author reply 896-7. doi: 10.1016/S0140-6736(08)60404-3. No abstract available.

PMID:
18342678
12.

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW; WISDOM group.

BMJ. 2007 Aug 4;335(7613):239. Epub 2007 Jul 11.

13.

Isocyanate exposure and occupational asthma: a case-referent study.

Meredith SK, Bugler J, Clark RL.

Occup Environ Med. 2000 Dec;57(12):830-6.

14.

Reported incidence of occupational asthma in the United Kingdom, 1989-97.

McDonald JC, Keynes HL, Meredith SK.

Occup Environ Med. 2000 Dec;57(12):823-9.

15.

Work-related respiratory disease in the United Kingdom, 1989-1992: report on the SWORD project.

Meredith SK, McDonald JC.

Occup Med (Lond). 1994 Sep;44(4):183-9.

PMID:
7949060
16.

SWORD '93. Surveillance of work-related and occupational respiratory disease in the UK.

Sallie BA, Ross DJ, Meredith SK, McDonald JC.

Occup Med (Lond). 1994 Sep;44(4):177-82.

PMID:
7949059
17.

Tuberculosis and HIV: estimates of the overlap in England and Wales.

Watson JM, Meredith SK, Whitmore-Overton E, Bannister B, Darbyshire JH.

Thorax. 1993 Mar;48(3):199-203.

18.

Deaths in adults with notified pulmonary tuberculosis 1983-5.

Cullinan P, Meredith SK.

Thorax. 1991 May;46(5):347-50.

Supplemental Content

Loading ...
Support Center